GSK says Paxil CR manufacturing problems are over
UK-headquartered pharma giant GlaxoSmithKline says it has overcome the manufacturing problems that caused it to voluntarily withdraw its antidepressant Paxil CR (paroxetine) and diabetes drug Avandamet (metformin and rosiglitazone) from the US market...